Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05484219
Other study ID # 9f
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date August 31, 2027

Study information

Verified date April 2024
Source Sklifosovsky Institute of Emergency Care
Contact Alexander Dmitriev, MD
Phone +7 (916) 423-54-08
Email dmitriev@neurosklif.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to assess accuracy, advantages of functional neuronavigation and calculate safe distance from motor areas to brain tumors and vascular malformations in image-guided surgery.


Description:

Functional images (functional magnetic resonance imaging (fMRI), transcranial magnetic stimulation (TMS), tractography) loaded in neuronavigation are called functional navigation. It is usually combined with anatomical data and allows to display eloquent brain areas. Currently there are plenty of studies concerning possibilities of it's use. In our research we plan to confirm this data and to supplement them with calculating a safe distance from motor areas to various mass lesions in preoperative scans where neurological deficits is not likely to appear after surgery. In case of success this data can be a foundation for further researches specifying indications for use of intraoperative neuromonitoring and possibility of it's replacement with functional navigation in some cases. The purpose of the study is to assess accuracy, advantages of functional neuronavigation and calculate safe distance from motor areas to brain tumors and vascular malformations in image-guided surgery. For each patient a surgeon intraoperatively will assess locations of motor cortex and corticospinal tract found with direct cortical and subcortical stimulation and capture them. After surgery he will compare this data with functional preoperative scans and virtual motor centers constructed based on tractography. Influence of various factors on precision of functional navigation will be studied and safe distance between motor brain areas and mass lesion borders will be calculated.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date August 31, 2027
Est. primary completion date August 31, 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years to 79 Years
Eligibility Inclusion Criteria: - all intracranial tumors - arteriovenous malformations - cavernous malformations - supratentorial localization - newly diagnosed - age 18-79 years - unaltered consciousness - error of patient registration in neuronavigation no more than 2 mm - possibility to perform "positive mapping" strategy Exclusion Criteria: - contraindications to magnetic resonance imaging or transcranial magnetic stimulation - inability to build tractography in neuronavigation - predicting of intraoperative brain shift 6 mm and more without possibility to correct it - real intraoperative brain shift 6 mm and more without possibility to correct it - previously performed brain radiotherapy - pregnancy - breast feeding

Study Design


Intervention

Device:
Functional navigation
Surgeon removes brain tumor or vascular malformation and assesses location of motor areas with functional navigation and intraoperative neuromonitoring

Locations

Country Name City State
Russian Federation Sklifosovsky Institute of Emergency Care Moscow

Sponsors (1)

Lead Sponsor Collaborator
Sklifosovsky Institute of Emergency Care

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of functional navigation (in millimeters) Maximal distance from the most remote margin of cortical hand/leg motor area or corticospinal tract in the area of corona radiata in functional navigation to the nearest margin of this area/tract in direct cortical/subcortical stimulation Intraoperatively
Primary Accuracy of location of cortical hand/leg motor area, built according to tractography (in millimeters) Maximal distance from the most remote margin of cortical hand/leg motor area, built according to tractography and loaded into navigation, to the nearest margin of this area in direct cortical stimulation Intraoperatively
Secondary Constancy of location of cortical hand/leg motor area in fMRI/TMS in relation to precentral gyrus (in millimeters) Maximal distance from the most remote margin of cortical hand/leg motor area in fMRI/TMS to the nearest margin of precentral gyrus Within 2 days before surgery
Secondary Factors, violating precision of fMRI/TMS/tractography Which factors lead to disappearing, thinning and dislocation of cortical hand/leg motor areas and corticospinal tract in fMRI/TMS/tractography Within 2 days before surgery
Secondary Motor function (in grades) Motor function is assessed in Medical Research Council scale Within 10 days after surgery
Secondary Distance to stop resection border (in millimeters) Minimal distance from the nearest margin of cortical hand/leg motor area or corticospinal tract to the nearest border of resection of tumor/vascular malformation Intraoperatively
Secondary Safe resection distance in functional navigation (in millimeters) This outcome is only measured in patients with no deterioration of motor function after surgery. Safe resection distance = accuracy of functional navigation + distance to stop resection border Within 10 days after surgery
Secondary Duration of direct cortical and subcortical mapping (in minutes) How long did it take to perform direct cortical and subcortical mapping Intraoperatively
Secondary Extent of resection (in percents) Extent of resection = (preoperative tumor volume - postoperative tumor volume) / preoperative tumor volume x 100 Within 48 hours after surgery
Secondary Karnofsky performance status (in percents) Assessment of patients' possibilities to self-service in Karnofsky Performance Status scale Within 10 days after surgery
Secondary Cerebral complications Which cerebral complications arose after surgery From admission to intensive care unit after surgery till hospital discharge, up to 365 days
See also
  Status Clinical Trial Phase
Recruiting NCT03306836 - Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2 N/A
Recruiting NCT03306823 - Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1 N/A
Completed NCT01347307 - Stereotactic Body Radiotherapy for Spine Tumors N/A
Recruiting NCT02042326 - Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations Phase 2
Recruiting NCT05484245 - Sonography-guided Resection of Brain Mass Lesions N/A
Recruiting NCT05477680 - Intraoperative Brain Shift Calculation Study N/A
Completed NCT03656211 - Fertility After Diagnosis and Management of Acquired Uterine Arteriovenous Malformation
Completed NCT04246125 - Patient Skin Dose in Interventional Radiology
Recruiting NCT02879071 - Long Term Follow-up After Embolization of Brain Arteriovenous Malformations
Terminated NCT01801488 - Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm N/A
Recruiting NCT06259292 - Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Recruiting NCT02098252 - Treatment of Brain AVMs (TOBAS) Study N/A
Completed NCT02378883 - Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study N/A
Completed NCT00783523 - Influence of MMP on Brain AVM Hemorrhage Phase 1
Recruiting NCT05276934 - Brain Imaging After Non-traumatic Intracranial Hemorrhage (SAVEBRAINPWI)
Recruiting NCT03031873 - Evaluation of Susceptibility-weighted Magnetic Resonance Imaging and 4d-time-resolved Magnetic Resonance Angiography in Brain Arteriovenous Malformations N/A
Withdrawn NCT02079818 - Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System Phase 4
Completed NCT01381952 - Image Quality and Radiation Dose in Angiography N/A
Active, not recruiting NCT05418816 - SelfWrap-Assisted Arteriovenous Fistulas N/A
Active, not recruiting NCT03559556 - Treating Arteriovenous Malformation With Stereotactic Radiosurgery Using CT Angiography for Treatment Planning Early Phase 1